DR. DERVAUX
ActiveSummary
DR. DERVAUX has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.0m and a net result of €203,994. Equity is growing by about 8.3% per year across the filed financial years. Its solvency ranks better than 95% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Dr. Dervaux
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, eenvoudige beslissing van de zaakvoerder(s)” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Één of meer, natuurlijke personen of rechtspersonen,hoeven geen aandeelhouder te zijn” (deed in Dutch)“Zaakvoerder(s), algemene kosten los van representatie-,reis-en verplaatsingskosten” (deed in Dutch)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Overlijden vennoot meteen melden aan Orde der artsen, contant of ten laatste binnen maand na definitieve vaststelling prijs” (deed in Dutch)
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Ontbinding op elk moment door beslissing AV beslissende in vormen vereist voor statutenwijziging, Artikel 27” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Bij gebrek andere benoeming bestuurder(s) in functie als vereffenaar(s) bij ontbinding, Artikel 28” (deed in Dutch)